US Patent Issued to ECP Pharma on Aug. 26 for "Methods of treatment with combinations of cannabidiol and psilocybin" (Canadian, American Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,007, issued on Aug. 26, was assigned to ECP Pharma (Richmond Hill, Canada).

"Methods of treatment with combinations of cannabidiol and psilocybin" was invented by Nitin Anand (Richmond Hill, Canada), Michael E. Hoffer (Miami), Moiz Rangwalla (Richmond Hill, Canada), Andy Mera (Richmond Hill, Canada) and Gilberto Iragorri (Richmond Hill, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods for treating brain injuries that include administering to a patient a first dosage of about 100 mg to about 500 mg of cannabidiol (CBD) and administering to the patient, concomitantly with the first dosage, a second dosage of abou...